Abstract
Twenty-one patients with angina pectoris were treated with adrenergic beta-receptor antagonists. Previously the resting heart rate had been used as a guide to treatment, a reduction in the rate to 55-60 beats/min without symptomatic improvement indicating failure of medical treatment. These patients were re-evaluated before coronary arteriography using the peak-exercise heart rate as an index of adrenergic beta-receptor antagonism. The dose of beta-blocking drugs was increased to produce a peak-exercise heart rate of less than 100 beats/min or a consistent rate of 100-125 beats/min which would not lessen in spite of progressive dose increments. The resting heart rate was ignored. On these criteria 15 patients previously considered to have responded inadequately to beta-blockade responded satisfactorily and were therefore removed from the waiting list for coronary arteriography. They all remained well up to two years later. Six patients failed to respond and had coronary arteriography with a view to surgical treatment. Reliance on the resting heart rate as the index of optimum adrenergic beta-receptor antagonism is likely to lead to premature or unnecessary referral for surgery; the failure of beta-blockade in the treatment of angina pectoris can be determined simply and accurately by using peak-exercise heart rate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adams D. F., Fraser D. B., Abrams H. L. The complications of coronary arteriography. Circulation. 1973 Sep;48(3):609–618. doi: 10.1161/01.cir.48.3.609. [DOI] [PubMed] [Google Scholar]
- Aronow W. S., Stemmer E. A. Bypass graft surgery versus medical therapy of angina pectoris. Am J Cardiol. 1974 Mar;33(3):415–420. doi: 10.1016/0002-9149(74)90325-7. [DOI] [PubMed] [Google Scholar]
- GILLAM P. M., PRICHARD B. N. USE OF PROPRANOLOL IN ANGINA PECTORIS. Br Med J. 1965 Aug 7;2(5457):337–339. doi: 10.1136/bmj.2.5457.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gott V. L. Outlook for patients after coronary artery revascularization. Am J Cardiol. 1974 Mar;33(3):431–437. doi: 10.1016/0002-9149(74)90328-2. [DOI] [PubMed] [Google Scholar]
- Jackson G., Atkinson L., Oram S. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. Br Med J. 1975 Mar 29;1(5960):708–712. doi: 10.1136/bmj.1.5960.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kannel W. B., Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol. 1972 Feb;29(2):154–163. doi: 10.1016/0002-9149(72)90624-8. [DOI] [PubMed] [Google Scholar]
- Livesley B., Catley P. F., Campbell R. C., Oram S. Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Br Med J. 1973 Feb 17;1(5850):375–378. doi: 10.1136/bmj.1.5850.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Logue R. B., Robinson P. H. Medical management of angina pectoris. Circulation. 1972 Dec;46(6):1132–1145. doi: 10.1161/01.cir.46.6.1132. [DOI] [PubMed] [Google Scholar]
- Master A. M., Jaffe H. L. Propranolol vs. saphenous vein graft bypass for impending infarction (preinfarction syndrome). Am Heart J. 1974 Mar;87(3):321–326. doi: 10.1016/0002-8703(74)90073-8. [DOI] [PubMed] [Google Scholar]
- Thadani U., Sharma B., Meeran M. K., Majid P. A., Whitaker W., Taylor S. H. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20;1(5846):138–142. doi: 10.1136/bmj.1.5846.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]